WO2009125140A3 - Traitement des migraines sans aura chez les femmes enceintes par inhalation de dioxygene gazeux - Google Patents

Traitement des migraines sans aura chez les femmes enceintes par inhalation de dioxygene gazeux Download PDF

Info

Publication number
WO2009125140A3
WO2009125140A3 PCT/FR2009/050521 FR2009050521W WO2009125140A3 WO 2009125140 A3 WO2009125140 A3 WO 2009125140A3 FR 2009050521 W FR2009050521 W FR 2009050521W WO 2009125140 A3 WO2009125140 A3 WO 2009125140A3
Authority
WO
WIPO (PCT)
Prior art keywords
aura
pregnant women
migraines
inhalation
treatment
Prior art date
Application number
PCT/FR2009/050521
Other languages
English (en)
Other versions
WO2009125140A2 (fr
Inventor
Marc Lemaire
Nathalie Noel
Original Assignee
L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude filed Critical L'air Liquide, Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude
Priority to EP09731419A priority Critical patent/EP2278980A2/fr
Priority to CA2711212A priority patent/CA2711212A1/fr
Publication of WO2009125140A2 publication Critical patent/WO2009125140A2/fr
Publication of WO2009125140A3 publication Critical patent/WO2009125140A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Médicament inhalable contenant du dioxygène gazeux (02) en une proportion supérieure à 22% en volume destiné à traiter, à minimiser ou à prévenir un état migraineux de type sans aura chez une femme enceinte.
PCT/FR2009/050521 2008-04-02 2009-03-30 Traitement des migraines sans aura chez les femmes enceintes par inhalation de dioxygene gazeux WO2009125140A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP09731419A EP2278980A2 (fr) 2008-04-02 2009-03-30 Traitement des migraines sans aura chez les femmes enceintes par inhalation de dioxygene gazeux
CA2711212A CA2711212A1 (fr) 2008-04-02 2009-03-30 Traitement des migraines sans aura chez les femmes enceintes par inhalation de dioxygene gazeux

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0852174A FR2929513B1 (fr) 2008-04-02 2008-04-02 Traitement des migraines sans aura chez le femmes enceintes par inhalation de dioxygene gazeux.
FR0852174 2008-04-02

Publications (2)

Publication Number Publication Date
WO2009125140A2 WO2009125140A2 (fr) 2009-10-15
WO2009125140A3 true WO2009125140A3 (fr) 2009-12-17

Family

ID=40120306

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2009/050521 WO2009125140A2 (fr) 2008-04-02 2009-03-30 Traitement des migraines sans aura chez les femmes enceintes par inhalation de dioxygene gazeux

Country Status (4)

Country Link
EP (1) EP2278980A2 (fr)
CA (1) CA2711212A1 (fr)
FR (1) FR2929513B1 (fr)
WO (1) WO2009125140A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3013596B1 (fr) 2013-11-26 2015-12-25 Air Liquide Sante Int Traitement des migraines chroniques par inhalation d’oxygene

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812545A1 (fr) * 2000-08-03 2002-02-08 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
FR2858233A1 (fr) * 2003-07-30 2005-02-04 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
EP1541156A1 (fr) * 2003-12-08 2005-06-15 Air Liquide Santé (International) Médicament gazeux inhalable à base d'argon pour le traitement des neuro-intoxications
FR2914632A1 (fr) * 2007-04-06 2008-10-10 Air Liquide Melange gazeux a base de o2 de n2o destine a prevenir ou a diminuer l'hyperalgesie

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812545A1 (fr) * 2000-08-03 2002-02-08 Air Liquide Sante Int Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur
FR2858233A1 (fr) * 2003-07-30 2005-02-04 Air Liquide Sante Int Medicament gazeux inhalable a base de xenon et de protoxyde d'azote
EP1541156A1 (fr) * 2003-12-08 2005-06-15 Air Liquide Santé (International) Médicament gazeux inhalable à base d'argon pour le traitement des neuro-intoxications
FR2914632A1 (fr) * 2007-04-06 2008-10-10 Air Liquide Melange gazeux a base de o2 de n2o destine a prevenir ou a diminuer l'hyperalgesie

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MAY A ET AL: "EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias.", EUROPEAN JOURNAL OF NEUROLOGY : THE OFFICIAL JOURNAL OF THE EUROPEAN FEDERATION OF NEUROLOGICAL SOCIETIES OCT 2006, vol. 13, no. 10, October 2006 (2006-10-01), pages 1066 - 1077, XP002508962, ISSN: 1468-1331 *
ROZEN TODD D: "High oxygen flow rates for cluster headache.", NEUROLOGY 10 AUG 2004, vol. 63, no. 3, 10 August 2004 (2004-08-10), pages 593, XP002508961, ISSN: 1526-632X *
See also references of EP2278980A2 *

Also Published As

Publication number Publication date
WO2009125140A2 (fr) 2009-10-15
FR2929513B1 (fr) 2010-09-17
CA2711212A1 (fr) 2009-10-15
EP2278980A2 (fr) 2011-02-02
FR2929513A1 (fr) 2009-10-09

Similar Documents

Publication Publication Date Title
HK1146485A1 (fr)
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
MX2009008825A (es) Nuevos metodos de terapia anticolinergica.
WO2009008001A3 (fr) Dispositif d'inhalation
WO2011106376A3 (fr) Utilisation de microvésicules dans le traitement d'affections médicales
TN2011000466A1 (en) Substituted 2-acetamido -5-aryl-1, 2, 4- triazolones and use thereof
WO2012110770A3 (fr) Composition pharmaceutique
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
UA102238C2 (en) 4-(4-cyano-2-thioaryl)dihydro-pyrimidinones and use thereof
MX2013003060A (es) Terapia de combinacion para tratar infeccion por hcv.
WO2011141685A3 (fr) Compositions nasales a visee systemique a base de cocoyl proline ou d'au moins un de ses constituants
TN2012000457A1 (en) Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
NZ631429A (en) Porous carbon particles for use in the treatment or prevention of liver disease
MX2009006913A (es) Uso de derivados de acido de piranona sustituidos para el tratamiento del sindrome metabolico.
WO2012051339A3 (fr) Procédés et compositions pour traiter des pathologies respiratoires en utilisant du plasma enrichi en plaquettes
FI3613421T3 (fi) Asetyylisalisyylihappo tromboembolisen tapahtuman riskin pienentämiseksi
WO2008148573A3 (fr) Médicaments contenant une combinaison de principes actifs pour traiter les symptomes allergiques
WO2014007781A3 (fr) Compositions d'inhalation
WO2010121675A3 (fr) Thiazolyl-benzimidazoles
EP2585067A4 (fr) Composé pour le traitement des entérovirus
MX2014002465A (es) Composiciones acuosas que comprenden arbekacina.
MY179794A (en) Compound composition for inhalation used for treating asthma
MX2009001433A (es) Nucleosidos para suprimir o reducir el desarrollo de resistencia en terapia citostatica.
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
WO2009125140A3 (fr) Traitement des migraines sans aura chez les femmes enceintes par inhalation de dioxygene gazeux

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09731419

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2711212

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009731419

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE